Scientists release a draft genome of the virus that has been identified in 41 patients.

The midwestern state has quietly laid the groundwork for a biotech hub.

A technique called Mendelian randomization is overturning the conclusions of observational studies in public health. But researchers question whether the method can overcome its fundamental limitations.

The company and its partner halted two clinical trials for futility early this year, but now say they’ll seek approval for aducanumab.

Men had better fat-burning results when they had breakfast after cycling instead of beforehand.

Many early-career clinical scientists receiving support through the NIH’s Loan Repayment Program have accepted disallowed industry funding, Science reveals.

Two clinical trial participants—one with β-thalassemia and one with sickle cell disease—appeared to benefit from the gene-editing treatments with minimal side effects, according to the companies.

The US Food and Drug Administration halts a study by Solid Biosciences after a patient experiences severe side effects following treatment.

The initial findings from a small clinical trial of patients with multiple myeloma or sarcoma suggest that gene-edited immunotherapy is safe.